Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in … GMT Guilcher, TH Truong, SL Saraf, JJ Joseph, D Rondelli, MM Hsieh Seminars in hematology 55 (2), 87-93, 2018 | 67 | 2018 |
CAR T-cell therapy for patients with multiple myeloma: current evidence and challenges MJ Rendo, JJ Joseph, LM Phan, CB DeStefano Blood and lymphatic cancer: targets and therapy, 119-136, 2022 | 41 | 2022 |
Outcome of multiple myeloma with chromosome 1q gain and 1p deletion after autologous hematopoietic stem cell transplantation: propensity score matched analysis A Varma, D Sui, DR Milton, G Tang, N Saini, O Hasan, A Mukherjee, ... Biology of Blood and Marrow Transplantation 26 (4), 665-671, 2020 | 33 | 2020 |
Patient-reported outcomes for cancer patients with hematological malignancies undergoing chimeric antigen receptor T cell therapy: a systematic review M Kamal, J Joseph, U Greenbaum, R Hicklen, P Kebriaei, SA Srour, ... Transplantation and cellular therapy 27 (5), 390. e1-390. e7, 2021 | 25 | 2021 |
When there is no match, the game is not over: alternative donor options for hematopoietic stem cell transplantation in sickle cell disease JJ Joseph, AA Abraham, CD Fitzhugh Seminars in hematology 55 (2), 94-101, 2018 | 24 | 2018 |
Outcomes of second allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia FF Yalniz, RM Saliba, U Greenbaum, J Ramdial, U Popat, B Oran, ... Transplantation and cellular therapy 27 (8), 689-695, 2021 | 18 | 2021 |
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive … C Saberian, N Abdel-Wahab, A Abudayyeh, H Rafei, J Joseph, G Rondon, ... Journal for immunotherapy of cancer 9 (2), 2021 | 16 | 2021 |
Ifosfamide-induced metabolic encephalopathy in 2 patients with cutaneous T-cell lymphoma successfully treated with methylene blue A Vakiti, R Pilla, M Alhaj Moustafa, JJ Joseph, AG Shenoy Journal of Investigative Medicine High Impact Case Reports 6, 2324709618786769, 2018 | 15 | 2018 |
Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement S Akin, C Hosing, I Khouri, S Ahmed, A Alousi, N Fowler, J Joseph, ... Blood Advances 6 (7), 2267-2274, 2022 | 8 | 2022 |
Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis HS Murthy, MJ Zhang, K Chen, S Ahmed, U Deotare, S Ganguly, ... Blood advances 7 (22), 7007-7016, 2023 | 7 | 2023 |
Acquired coagulopathy with immune checkpoint inhibitors: an underrecognized association between inflammation and coagulation JJ Joseph, A Rajan, JL Gulley, S Ito, CM Kessler JTO Clinical and Research Reports 1 (3), 100049, 2020 | 6 | 2020 |
Impact of cell of origin classification on survival outcomes after autologous transplantation in relapsed/refractory diffuse large B cell lymphoma J Joseph, J Ma, F Hennawy, MN Abdulrazzaq, N Saini, RD Patel, ... Transplantation and Cellular Therapy 27 (5), 404. e1-404. e5, 2021 | 5 | 2021 |
Transplantation outcomes of myelofibrosis with busulfan and fludarabine myeloablative conditioning J Joseph, SA Srour, DR Milton, JL Ramdial, NY Saini, AL Olson, Q Bashir, ... Transplantation and Cellular Therapy 29 (12), 770. e1-770. e6, 2023 | 2 | 2023 |
Fresh versus cryopreserved peripheral stem cell for autologous transplantation in multiple myeloma: An analysis of short-term outcomes J Joseph, V Wookey, B Randolph, JC Chandler, D Marjoncu, K Holman, ... Blood 136, 9-10, 2020 | 2 | 2020 |
Chronic cough due to angiotensin-converting enzyme inhibitors. DW Nuss, GD Lyons, JJ Joseph Ear, Nose, & Throat Journal 69 (9), 649, 651-649, 651, 1990 | 2 | 1990 |
A Mildly Symptomatic Middle-Aged Woman with INT-1 Primary Myelofibrosis J Joseph, U Popat Clinical Lymphoma, Myeloma and Leukemia 20, S19, 2020 | 1 | 2020 |
Myeloablative fludarabine and busulfan regimen in myelofibrosis: Long term outcomes and analysis of prognostic factors. J Joseph, DR Milton, J Chen, G Alatrash, AM Alousi, Q Bashir, SO Ciurea, ... Journal of Clinical Oncology, 2020 | 1 | 2020 |
Characteristics and Outcomes of Stem Cell Transplant Patients during the COVID-19 Era: A Systematic Review and Meta-Analysis M Kamal, M Baudo, J Joseph, Y Geng, O Mohamed, M Rahouma, ... Healthcare 12 (5), 530, 2024 | | 2024 |
233 A real-world case of second chimeric antigen receptor t-cell therapy J Joseph, D Marjoncu, K Holman, S Leidy Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
Clinical Outcomes after Immunotherapies in Cancer Setting during COVID-19 Era: A Systematic Review and Meta-Regression M Kamal, M Baudo, J Joseph, Y Geng, A Qdaisat Reports 5 (3), 31, 2022 | | 2022 |